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19 ABSTRACT: 
20 
21 Skeletal muscle is integral to the metabolism and utilisation of macronutrients; however, 
22 substantial muscle loss and morphological changes occur with ageing. These are associated with 
23 loss of muscle function and accelerate rapidly from the age of 60 years, leading to the conditions of 
24 sarcopenia and frailty. As the relationship between muscle ageing and macronutrient metabolism 
25 and utilisation has seen limited research to date, this review focuses on the interactions between 
26 skeletal muscle changes during ageing, metabolism and utilisation of fat, carbohydrates, and overall 
27 energy expenditure. 
28 
29 Skeletal muscle contributes less to resting energy expenditure during ageing, 
30 potentially contributing to onset of obesity from middle-age. Age-related changes to skeletal muscle 
31 lead to glucose dysregulation, with consequent reduction in glycaemic control, increased insulin 
32 resistance, and ultimately onset of type 2 diabetes. Recent studies indicate that high total fat and 
33 saturated fatty acid (SFA) intake are detrimental to skeletal muscle, while higher intakes of 
34 polyunsaturated fatty acids are protective. Age-associated changes in skeletal muscle may also 
35 reduce total fatty acid utilisation. 
36 
37 In conclusion further research is needed to understand the relationships between 
38 macronutrient metabolism and utilisation and age-related changes to skeletal muscle. No dietary 
39 recommendations exist specifically for skeletal muscle health during ageing, but we advise 
40 individuals to follow healthy eating guidelines, by consuming sufficient protein, fruits and 
41 vegetables, and limited SFA and to maintain physically-active lifestyles. Clinicians responsible for 
42 managing type 2 diabetes need to be aware of the growing evidence relating age-related skeletal 
43 muscle changes to diabetes onset and progression. 
44 
45 
46 
47 
48 
49 
50 
51 
52 
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53 Introduction 
54 
55 Maintaining skeletal muscle mass and function is important for health, but loss of both occurs as a 
56 natural consequence of ageing. This loss starts from mid-life, as early as 40 years of age, and 
57 progresses more rapidly over the age of 60 years (1-4). Sarcopenia, the presence of low skeletal mass 
58 and function, is the result of the gradual decline with age in muscle strength as well as mass. The 
59 most recent definition of sarcopenia focuses on functional aspects whilst acknowledging that the 
60 role of skeletal muscle mass requires further research (5-7). Sarcopenic obesity is the presence of 
61 sarcopenia, as low lean mass, in combination with obesity; this condition is also increasingly 
62 prevalent in older populations (1, 8-11). Moreover, sarcopenia and age-related skeletal muscle loss are 
63 key contributors to frailty. Research and clinical interest for sarcopenia have largely focused on the 
64 functional consequences of the loss of muscle with age, such as reduced mobility and increased falls 
65 and fractures. There has been less focus on the metabolic and homeostatic importance of skeletal 
66 muscle and the consequences of this skeletal muscle loss on nutritional biochemistry and 
67 metabolism and utilisation of macronutrients. (1, 12-17) 
68 
69 Skeletal muscle is integral to the metabolism and utilisation of the macronutrients protein, fat, and 
70 carbohydrate, as well as overall energy metabolism. However, the age-related loss of skeletal 
71 muscle mass, changes in skeletal muscle morphology, and the consequent effects and interactions 
72 on metabolism of macronutrients are much less appreciated (12). 
73 
74 The prevalence of sarcopenia is high in residential care and in the community (14%-33% and 29%, 
75 respectively) with rates predicted to double from current prevalence by 2015 (6, 18). Sarcopenia is 
76 also a component of frailty, which has a prevalence of 25% in those over the age of 80 (19). The age- 
77 related losses and changes to morphology of skeletal muscle also have consequences for 
78 carbohydrate metabolism, as this is used by skeletal muscle as glucose, released by digestion of 
79 carbohydrate. This has implications for the onset of insulin resistance and type 2 diabetes (1, 2, 13, 14, 
80 20-23). Loss of skeletal muscle also has implications for energy expenditure and concomitant risk of 
81 onset of obesity. Given the prevalence of sarcopenia, frailty, obesity and type 2 diabetes in 
82 adulthood in Western populations, the overall costs and burden to health and social care 
83 are vast (20, 21, 24). These costs and the burden to society will also increase in the future, given the 
84 predicted increase in the prevalence of sarcopenia and its associated conditions, and the increasing 
85 age profile of Western populations. 
86 
87 As the nutritional and metabolic consequences of the loss of skeletal muscle, and changes to 
88 skeletal muscle quality, have received less attention than the functional consequences, these aspects 
89 form the focus of this review (12). This manuscript provides an overview of the metabolic 
90 consequences of age-related changes and loss of skeletal muscle mass on the metabolism of 
91 macronutrients, particularly fat and fatty acids, and carbohydrate, and effects on overall energy 
92 expenditure during middle and older age. Morphological changes to fibre type and muscle 
93 composition in relation to macro-nutrient metabolism and utilisation are highlighted (25). The effects 
94 of morphological changes and losses of skeletal muscle mass on resting energy expenditure, and 
95 concomitant risk of onset of obesity, as well as on insulin resistance, control of blood glucose, and 
96 the contribution to the onset of type 2 diabetes are described (1, 2, 13, 14, 20, 21). The relationships 
97 between the effects of diabetes on further changes and loss of skeletal muscle, as well as the 
98 potential impact of certain fatty acids on quantity and morphology of skeletal muscle, are also 
99 covered, and are illustrated in Figure 1. 
100 
101 
102 
103 
104 
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105 The effects of ageing on skeletal muscle mass and morphology 
106 
107 Measuring skeletal muscle & terminology 
108 
109 A number of methods are available for measuring total body composition in vivo: ranging from 
110 bioelectrical impedance to dual-energy X-ray absorptiometry. Measures of skeletal muscle mass are 
111 typically calculated from these methods. In reference man (a traditional term, arising from early 
112 research in this area, that describes the typical body composition of adult males of an average body 
113 weight) total body mass consists of around 19% fat mass (FM) and 81% fat free mass (FFM), 91% 
114 of which is lean soft tissue mass, with the remainder consisting of bone (26-32). However, in women 
115 the proportion of fat mass in the body is, in the main, greater than in men and so is associated with a 
116 correspondingly lower proportion of fat free mass, see also section, ‘loss of skeletal muscle mass’ 
117 for further details. Development of three- and four-compartment methods for measuring skeletal 
118 muscle mass (SMM) in populations is relatively recent, and much of the literature relating to 
119 sarcopenia and skeletal muscle refers to FFM, which has been considered a suitable measure of 
120 skeletal muscle mass, given that contributions from bone are small(3, 26-30, 33). Appendicular lean 
121 mass (ALM) or appendicular skeletal muscle mass (ASM) is the sum of lean tissue in the arms and 
122 legs (26-30). 
123 
124 Scaling for body size 
125 
126 Since fat free mass increases with greater body weight and height, studies in humans are scaled for 
127 body size (29, 34-36). Scaling can be by: height, height2, as a percentage of total body weight, or by 
128 BMI. 
129 
130 Loss of skeletal muscle mass 
131 
132 Skeletal muscle, measured as FFM, accounts for around 70-80% of body weight in men and 65- 
133 75% in women of middle and early older age (37). Losses of skeletal muscle mass are gradual and 
134 progressive, ranging from 0.5% to 1% per year, starting around middle age, with rates increasing 
135 over the age of 60 years (1-3). Men experience greater rates of loss during older age, although their 
136 FFM, as a proportion of body size, is greater than in women at all life stages. 
137 
138 Muscle morphology changes during aging and links to fat, carbohydrate, and energy metabolism 
139 
140 Skeletal muscle is composed of three distinct types of muscle fibre, categorised by their energy 
141 metabolism and their myosin structures: slow-twitch, oxidative, Type I fibres; fast-twitch, 
142 oxidative-glycolitic, Type IIa fibres; and fast-twitch, glycolytic, Type IIb fibres. Each category of 
143 fibre also shows different capacities for fatty acid utilisation, with Type I fibres contributing more 
144 to fatty acid oxidation and being more insulin-sensitive than Type IIb fibres (38). Human muscle 
145 shows multiple fibre types within a single muscle group, with different proportions of fibre types in 
146 each muscle; for example, the soleus muscle in the calf is mostly comprised of Type I fibres, while 
147 the vastus lateralis muscle in the thigh is largely Type II (39). These proportions are flexible, 
148 however, and muscle fibres can remodel their phenotypes to adapt to different circumstances, 
149 including ageing (40)  
150  
151 Aging is associated with a conversion of muscle fibres to slow-twitch, oxidative, Type I fibres, and 
152 Type II fibres are seen to atrophy and shrink in diameter, while Type I fibres are relatively 
153 unaffected (41). This may relate to damage, and ultimately breakage, experienced by muscle fibres 
154 during the ageing process (42). Further, the total number of muscle fibres in skeletal muscle 
155 decreases with age (43), along with the cross-sectional area of the muscle, which has been shown to 
156 decrease by 25-35% in older men and women (44, 45). See Wilkinson, Piasecki, and Atherton for a 
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157 review of muscle fibre loss and atrophy with ageing (46). Measures of cross-sectional area 
158 underestimate losses in muscle contractile tissue, as muscle ageing is also accompanied by 
159 infiltration of fatty and fibrotic tissue (47), which contributes to the disparity between mass and 
160 strength losses in sarcopenia. Fatty infiltration (myosteatosis) is related to the higher content of 
161 saturated ceramide and diacylglycerol fatty acids in older age (48). 
162 
163 Mitochondrial effects during aging and interaction with macronutrient metabolism 
164 
165 Mitochondria are also important in the context of ageing. In the cell, mitochondria are essential to 
166 metabolism as they use oxidative phosphorylation to produce a ready supply of adenosine 
167 trisphosphate (ATP), a fundamental energy unit for cellular processes. Mitochondria in skeletal 
168 muscle form complex, anisotropic networks (49) that supply energy to fuel muscle contraction. There 
169 are two distinct subpopulations of mitochondria: one directly beneath the sarcolemma, and the other 
170 between myofibrils (50). Slow-twitch oxidative muscle fibres contain many more mitochondria than 
171 fast-twitch glycolytic fibres, and are more resistant to fatigue due to the large amount of ATP 
172 generated by their mitochondria. The oxidative phosphorylation efficiency of mitochondria, their 
173 capacity to produce ATP, has been shown to decline with age (51), and is also influenced by insulin 
174 resistance, as discussed later in this review. Mitochondria also contribute to the ageing process: 
175 dysfunctional mitochondria accumulate with age, particularly in skeletal muscle (52), and they 
176 ultimately become senescent (53), losing the ability to proliferate. Dysfunctional mitochondria 
177 generate reactive oxygen species (ROS), and the damage associated with these is central to some 
178 pathologies, as well as ageing (54-56); these dysfunctional mitochondria produce a vicious cycle of 
179 damage and deterioration in ageing muscle. 
180 
181 The ligand binding nuclear receptors found in skeletal muscle are transcription factors involved in 
182 metabolic control within skeletal muscle; see Baskin for an elegant review (57). Peroxisome 
183 proliferator-activated receptors (PPARs) are critical regulators of the metabolic genes in striated 
184 muscle (58), with PPARα being involved in transcription of the genes required for fatty acid uptake 
185 or oxidation. PPARα activation induces fatty acid utilisation in skeletal muscle (59). Also 
186 peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC1α), along with PPARα, 
187 coordinates metabolic regulation within skeletal muscle, further regulating the GLUT4, cAMP 
188 response element binding protein and nuclear respiratory factors to mediate transcription of genes 
189 involved in fatty acid and glucose metabolism (57). 
190 
191 In summary, the total number and diameter of skeletal muscle fibres decreases with age, fibre type 
192 shifts to slow-twitch Type I fibres that are more insulin-resistant and do not utilise glucose. 
193 Mitochondria become dysfunctional, or senescent, and generate reactive oxygen species that further 
194 damage muscle. Further age-related changes in skeletal muscle morphology include infiltration of 
195 non-contractile material in muscle tissue, denervation, a reduction in the number of satellite cells, 
196 and a weakening of the connections between muscle and tendons. All of these have consequences 
197 for the functional capacity of skeletal muscle, as well as its ability to regenerate when damaged. The 
198 loss of skeletal muscle mass and morphological changes associated with ageing have the potential 
199 to impact directly on oxidation and utilisation of fatty acids as well as glucose utilisation and energy 
200 metabolism, see Table 1. 
201 
202 Protein metabolism and muscle 
203 
204 Skeletal muscle is the main reservoir of amino acids in the body; these are stored as protein, and are 
205 required for the maintenance of protein synthesis within skeletal muscle (2, 13, 14, 60-63). This store is 
206 activated during deficits of energy intake, and during periods of increased demand, to satisfy the 
207 energy requirements of the body through catabolism of protein and gluconeogenesis (2, 13, 14, 60-63). 
208 Thus, the loss of skeletal muscle mass with age diminishes reserves of amino acids, stored as 
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209 protein with the body. Maintaining the balance between protein synthesis, anabolism, and protein 
210 breakdown, catabolism, is also crucial to conservation of skeletal muscle during ageing (2, 12, 13, 61, 
211 64). However, several mechanisms of ageing disrupt this balance, leading to catabolism. Such 
212 mechanisms include ROS, circulation of inflammatory cytokines, and the insulin resistance that 
213 leads to type 2 diabetes (22, 65).Therefore, the onset of insulin resistance and type 2 diabetes disrupt 
214 protein synthesis, contributing to changes in skeletal muscle mass and morphology, as described 
215 later. 
216 
217 As the topic of protein in relation to skeletal muscle is covered in full elsewhere, newer aspects of 
218 research relating to skeletal muscle and its importance to metabolism of carbohydrate, fat, and 
219 energy metabolism are covered in the following sections. 
220 
221 The effects of ageing of skeletal muscle on energy expenditure and risk of obesity 
222 
223 Components of energy expenditure and balance between energy intake and energy expenditure 
224 
225 Total daily energy expenditure (TEE) comprises three main components: 1) resting energy 
226 expenditure (REE), also referred to as resting metabolic rate (RMR) or basal metabolic rate (BMR); 
227 2) the thermic effect of food; and 3) the energy expenditure associated with physical activity. See 
228 Figure 2 for an illustration of these. In adults, REE accounts for 60%-70% of total energy 
229 requirements in healthy adults (32, 66-69). The proportion of resting energy expenditure attributable to 
230 organ mass ranges from around 5% to 10% (32, 68, 69). FFM is the main predictor of REE, which is 
231 determined by the metabolism of macronutrients protein, carbohydrate, fat, and alcohol. The 
232 contribution of the thermic effect of food to TEE is estimated at around 10% of TEE. The 
233 contribution of habitual and discretionary physical activity to TEE is variable, ranging from around 
234 15% in very sedentary people to around 50% in those who are very physically active. TEE reduces 
235 during aging, partly due to reductions in habitual and discretionary physical activity but also due to 
236 the loss of metabolically-active FFM, which consists of both skeletal tissue and that found in the 
237 internal organs. 
238 
239 A balance must be maintained between energy expenditure and energy intake, derived from 
240 macronutrients and alcohol, in order to maintain a steady body weight, as described in Figure 2. 
241 Body weight increases when excess energy intake is consumed compared with total energy 
242 expended (TEE). 
243 
244 Metabolic rate decreases with age in relation to loss of skeletal muscle mass and in clinical 
245 conditions of ageing 
246 
247 In the early 20th  century, age-related reductions in basal metabolic rate were observed, with Lewis 
248 finding that ‘0.664 calories per hour per square meter per hour’ were lost per decade of age in men 
249 (70). That this was attributable to loss of skeletal muscle mass with age has been elaborated with 
250 further findings during this century in both men and women. Ravussin’s study in 1986 identified the 
251 key determinants of 24-hour energy expenditure in man, finding that FFM explained 81% of the 
252 variance in energy expenditure in an obese population (71). Furthermore, even after accounting for 
253 physical and spontaneous activity and the thermic effect of food, FFM remained the most important 
254 determinant of energy expenditure (71). Subsequent studies found that RMR was lower in older than 
255 in younger men, and this was attributable to the lower proportion of FFM in older men (72). Zurio 
256 and colleagues also found that differences in resting muscle metabolism partly accounted for the 
257 variance in metabolic rate amongst individuals of normal body weight (73). Overall, findings were 
258 summarised by Weinsier and colleagues in 1992 (74). 
259 
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260 Recent research also indicates that FFM is a key predictor of total energy expenditure even in 
261 highly active younger people (75). This study measured energy expenditure using the doubly-labelled 
262 water technique in military personnel engaged in intensive operations. Whilst physical activity was 
263 a key predictor of energy expenditure in this group (r = 0.9, P < 0.05) the association of energy 
264 expenditure with FFM was greater than that with total body mass (r = 0.32, P < 0.05; and r = 0.28, P 
265 < 0.05, respectively) even in this population with a high physical activity. 
266 
267 Sex-specific differences in the relationship between total FFM and REE have been explored 
268 further (67). In men and women aged 18-79 years, women experienced an earlier decline in SMM 
269 than men, starting at the age of 29 years versus 39 years in men. However, SMM, adjusted for FM, 
270 remained the main determinant of REE in both men and women, with R2  = 0.67 in women and R2 = 
271 0.66 in men (67). . More recent work also suggests that the proportion of FFM impacts on, and 
272 partially determines, energy intake and expenditure, via its mediating effect on RMR (76). 
273  
274  
274 
275 
276  
277  
278  
279 During ageing, the contribution of FFM to REE declines in parallel with the age-related decline in 
280 FFM, explaining 59.7% of the decrease in REE. This indicates that the importance of FFM to REE 
281 increases with age (67). This is particularly important in underweight older people with low FFM (74, 
282 77), and the situation is exacerbated in nonagenarians (78). Indeed, two recent studies found that 
283 decreased basal metabolic rate is an objective marker for sarcopenia and frailty in older adults (78, 
284 79). Thus, in elderly people who are underweight and have low physical activity, REE represents the 
285 greatest part of total energy expenditure (74, 77). 
286 
287 Overall, the contribution of FFM, as the component of total energy expenditure, increases with age 
288 as the contribution of physical activity declines. 
289 
290 The effects of age-related skeletal muscle loss on metabolic rate - 
291 and the onset of obesity 
292 
293 In middle and early-older-age the age-related decline in FFM and SMM may have implications for 
294 the onset of obesity. Obesity arises from the imbalance of energy intake and expenditure, and so the 
295 gradual loss of muscle mass with age has potential consequences for habitual energy expenditure 
296 and the energy imbalance that leads to the onset of obesity (2). Discretionary and habitual physical 
297 activity also declines during ageing, contributing to overall reductions in energy expenditure. Two 
298 studies found that skeletal muscle fibre-type proportion is related to obesity. The first found that 
299 obese men had a higher proportion of fast-twitch, Type II fibres in the vastus lateralis muscle (80). 
300 The second confirmed these findings in obese women and found that the effectiveness of a weight- 
301 loss intervention was positively related to the percentage of slow-twitch, Type I fibres, which 
302 contain a greater proportion of mitochondria than do fast twitch fibres (81), as discussed in the 
303 section ‘The effects of ageing on skeletal muscle mass and morphology’. 
304 
305 Robert Wolfe, in his important paper, calculated that every 10 kg of lean mass that is lost with 
306 age translates to a decrease in energy expenditure of around 100 kcal/d, assuming a constant rate 
307 of turnover (2). This is equivalent to an accumulation of around 4.7 kg FM per year, assuming 1 kg 
308 fat store represents 7,700 kcal. Clearly, this difference in energy expenditure would 
309 disproportionately affect older individuals, who tend to have lower levels of physical activity and 
310 thus greater potential to develop obesity, as well as sarcopenic obesity. 
311 
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312 In summary, the evidence is now clear that skeletal muscle contributes a lower proportion of resting 
313 energy expenditure to total energy expenditure during ageing, potentially contributing to onset of 
314 obesity from middle-age onwards. 
315 
316 Effects of ageing of skeletal muscle on glucose metabolism, insulin resistance and risk of type 2 
317 diabetes 
318 
319 Age-related changes in skeletal muscle, in terms of loss of quantity and morphology, impact on 
320 glucose metabolism, blood glucose control, insulin resistance, and onset of type 2 diabetes, as 
321 shown in Figure 3 with the mechanisms involved as follows (1, 2, 20, 21, 23, 82-84). Glucose, which arises 
322 from digestion of carbohydrate is released into the bloodstream. Skeletal muscle is the organ 
323 responsible for the greatest insulin-stimulated glucose disposal in the body, accounting for around 
324 75% of glucose uptake (85). When skeletal muscle contractile tissue is lost during ageing, this leads 
325 to lower glucose uptake from the circulation. This and the increase in fat and ceramide infiltration is 
326 a contributory cause of insulin resistance, which is itself associated with reduced skeletal muscle 
327 mitochondrial function in older adults (86); indeed, mitochondrial dysfunction and insulin resistance 
328 appear to reinforce one another in a feedback loop (87). See a review by Affourtit for more 
329 information on the links between mitochondrial function and insulin resistance (88). These links 
330 highlight an association between the loss of SMM and mitochondrial function with age with the 
331 onset of type 2 diabetes. Therefore, age-related changes in skeletal muscle have implications for the 
332 onset and treatment of type 2 diabetes (20, 82-84, 89). 
333 
334 Low skeletal muscle mass, sarcopenia, and dynapenia are associated with or predict incidence of 
335 type 2 diabetes 
336 
337 A number of cross-sectional studies have demonstrated that low SMM is associated with insulin 
338 resistance or type 2 diabetes (20, 90-96). Existing sarcopenia or dynapenia is also a risk factor for onset 
339 of diabetes, as is low SMM (97-99). An increased hazard risk of 2.05 (95% CI 1.73, 2.43) was 
340 associated with onset of type 2 diabetes over 9 years in those with the lowest MMI (ALM adjusted 
341 for weight), compared with the highest tertile of MMI, who had double the risk (100). Moreover, this 
342 increased risk of type 2 diabetes was due to relatively small differences in MMI at baseline of only 
343 5.4% between those at the greatest and least risk. Subsequently maintenance of appendicular 
344 skeletal muscle mass (ASM) was also found to be protective against the development of type 2 
345 diabetes in men but not women, independent of obesity (101). However, a further study contradicted 
346 this finding, as women with a higher skeletal muscle mass were at greater risk of incident type 2 
347 diabetes (102). 
348 
349 Impact of type 2 diabetes on skeletal muscle 
350 
351 Evidence is building that the presence of type 2 diabetes in older people leads to significant loss of 
352 SMM over time (100, 103). One study found that accelerated loss of SMM occurred in middle-aged 
353 and older women with diabetes (104); this is due to a number of disease processes, including the poor 
354 glycaemic control that is often associated with the existence of mild metabolic acidosis (95, 105, 106). 
355 That this is the case was confirmed in a study where treatment of diabetes with insulin attenuated 
356 the decline in muscle mass (107). 
357 
358 In summary, age-related changes to skeletal muscle lead to glucose dysregulation, with consequent 
359 reduction in glycaemic control, increased insulin resistance, and ultimately onset of type 2 diabetes, 
360 as shown in Figure 3 (20, 82-84, 89). These age-related changes in skeletal muscle also have 
361 implications for the progression of type 2 diabetes, with the onset of poor glycaemic control also 
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362 accelerating skeletal muscle loss and the morphological changes that occur with age, leading to a 
363 vicious cycle of damage to muscle, as in Figure 3. 
364 
365 Role of fat intake and metabolism on age-related muscle loss 
366 
367 Skeletal muscle is also central to the metabolism of dietary fat, with the fatty acids derived from fat 
368 being the main source of energy for resting and working muscle (2, 108, 109). As discussed earlier, the 
369 ligand-binding nuclear receptor PPARα, when bound to long chain fatty acids, activates 
370 transcription of genes involved in fatty acid uptake and oxidation, and robustly induces utilisation 
371 of fatty acids in muscle tissue (57). Likewise, PPAR and PPAR are also involved in regulating 
372 fatty acid metabolism in skeletal muscle. Thus, reduction in skeletal muscle mass during ageing 
373 may also reduce the capacity for fatty acid metabolism. Also, recent, but limited research in human 
374 and animal studies has identified the relevance of dietary fat acid intake to skeletal muscle in ageing 
375 (17, 110). 
376 
377 Dietary fat intake varies significantly in terms of the total amount and the proportion of different 
378 fatty acids. Indeed, all sources of fat are mixtures of the different classes of fatty acids, including 
379 saturated (SFA), monounsaturated (MUFA), and polyunsaturated (PUFA) fatty acids. Considering 
380 the range of different sources of fat used in food manufacture and meal preparation, the profile of 
381 different fatty acid intakes for different individuals within and between populations can be highly 
382 variable (111). 
383 
384 It is important to consider both that dietary fat is integral to the muscle membrane (the sarcolemma) 
385 and that fatty acids act as the dominant substrate for the production of ATP during aerobic exercise 
386 (108, 109). Long chain free fatty acids circulate in the blood, and protein transporters, including fatty 
387 acid binding protein in the plasma membrane (FABPpm), fatty acid translocase (FAT/CD36), and 
388 the fatty acid transport protein (FATP), facilitate their transfer across the sarcolemma (112). 
389 Moreover, the specific fatty acid profile of the diet is reflected in the fatty acid composition of the 
390 sarcolemma, although this may also be altered by other physiological process including exercise 
391 stimulation of skeletal muscle (113, 114). The profile of fatty acids is also relevant since fatty acids 
392 have been shown to be oxidised in a specific order of preference, with oleic and unsaturated fatty 
393 acids oxidised in preference to SFA (115). 
394 In terms of the mechanisms behind these associations, some studies have shown that dietary fat 
395 intake can affect inflammatory status, which may have consequences for skeletal muscle. Previous 
396 observational studies have suggested that both the total fat intake and the proportion of different 
397 fatty acids may be relevant in the mechanisms leading to skeletal muscle loss and sarcopenia (17, 116). 
398 In particular, high total fat and SFA intakes may be detrimental to skeletal muscle health, and 
399 higher proportions of PUFA (total, n-3 PUFA, n-6 PUFA), MUFA, and the PUFA to SFA ratio may 
400 be beneficial (17, 116).  However, the recent Scientific Advisory Committee on Nutrition report on 
401 SFA and health made no specific comments on the effects of SFA on skeletal muscle, due to a lack 
402 of research (117). As discussed above, inflammation pathways are intricately involved in the 
403 processes of ageing and sarcopenia. High intakes of total fat and SFA are typically viewed as risk 
404 factors for inflammation, while n-3 PUFA are more recognised for their anti-inflammatory 
405 properties and potential for increasing protein synthesis (17, 116, 118-120). However, despite this, a 
406 recent systematic review and meta-analysis of RCTs found little or no association of n-3, n-6 and 
407 total PUFA on skeletal muscle outcomes, largely due to insufficient evidence of high quality (16). 
408 One inflammatory mediator previously shown to be found in higher concentrations in older 
409 individuals is interleukin-6 (IL-6) (121). This molecule is produced in skeletal muscle and is, is 
410 known to affect both glucose and fatty acid metabolism in muscle (122). Indeed, it has been 
411 hypothesised that IL-6 is a key factor in insulin resistance, and thus increased concentrations in the 
412 elderly may have important metabolic consequences. 
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413 As described earlier with reference to insulin resistance, during ageing there is an increase in the 
414 lipid infiltration within skeletal muscle fibres (myosteatosis) and an associated reduction in the 
415 oxidative capacity of the muscle. This change in skeletal muscle composition is affected by dietary 
416 fat intake, as shown in animal work where significantly higher muscle lipid deposition was seen in 
417 mice fed on a high-fat diet versus those fed a control diet (123). This lipid deposition may lead to 
418 mitochondrial dysfunction, decreasing ATP production and increasing ROS production, and it may 
419 also result in insulin resistance. ROS can act as second messengers for TNF-α in skeletal muscle 
420 tissue and can result in NF-κB activation, causing an increase in IL-6 (124). The resulting increased 
421 inflammatory state may be of further detriment to normal skeletal muscle health. Observational 
422 study data has shown frail adults to have higher levels of intramuscular adipose tissue than non-frail 
423 individuals, and the quantity of intramuscular adipose tissue is significantly positively associated 
424 with IL-6 expression and protein within the muscle (125). It is not clear whether the predominant 
425 direction of the relationship is that an inflammatory environment in the muscle exacerbates lipid 
426 infiltration, or conversely that an increase in inflammatory signalling molecules is a result of fat 
427 infiltration, but both may occur. Irrespective of this, the close proximity of fat to the muscle in the 
428 event of inflammatory cytokine release is likely to result in more profound effects on skeletal 
429 muscle dysfunction than of a more systemic increase in inflammatory load. 
430 
431 In summary, there is an important role for fatty acids in skeletal muscle health during ageing 
432 through mechanisms including fatty acid infiltration and enhanced inflammatory status, with 
433 consequences for metabolism and further adverse knock-on effects to skeletal muscle mass and 
434 function, see Figure 4. While total fat intake is relevant, the balance between different fatty acids in 
435 the diet appears to be particularly important (121, 122). 
436 
437 Conclusions 
438 
439 Age-related changes in skeletal muscle in terms of quantity and morphology have important 
440 consequences for the metabolism and utilisation of macronutrients. Recent research indicates these 
441 age-related changes to skeletal muscle have the potential to impact directly on oxidation and 
442 utilisation of fatty acids as well as glucose utilisation and energy metabolism. The evidence is now 
443 clear that age-related changes to skeletal muscle contribute to lower REE during aging, potentially 
444 playing a part in the onset of obesity from middle-age onwards. The effects of age-related changes 
445 in skeletal muscle that lead to glucose dysregulation, reduction in glycaemic control, increased 
446 insulin resistance, and onset of type 2 diabetes are beginning to be recognised. That the onset of the 
447 poor glycaemic control also accelerates skeletal muscle loss and morphological changes leading to a 
448 vicious cycle of age-related muscle changes in those with type 2 diabetes is also important. There is 
449 also an important role for fatty acids in skeletal muscle health during ageing, from both total fat 
450 intake and the balance between different fatty acids in the diet, with metabolic consequences of 
451 fatty acid infiltration in muscle and altered inflammatory status causing negative effects on skeletal 
452 muscle mass and function. Further work is required to determine whether the role of fatty acids in 
453 skeletal muscle differs by sex and by age group. 
454 
455 Practical public health messages for people of middle and older age 
456 
457 There is a need to conserve skeletal muscle during middle and early older age, particularly for 
458 maintaining metabolic response to dietary macro-nutrients: (carbohydrate) glucose, fat, and protein 
459 during ageing. Whilst not the focus of this paper, there is also growing evidence that certain 
460 vitamins and minerals such as vitamin C, carotenoids, magnesium, and patterns of dietary intake are 
461 likely important for maintenance of skeletal muscle health, and could have a positive impact on 
462 protein synthesis in skeletal muscle (1, 12, 37, 126-131). 
463 
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464 To date there are no dietary recommendations specifically for older people, or for maintaining 
465 skeletal muscle health during ageing, and such recommendations need to be developed (2). We also 
466 do not know whether these recommendations would need to differ between men and women of 
467 older age. Until recommendations are made, research evidence suggests that public health 
468 practitioners should encourage individuals to follow healthy eating patterns that meet the current 
469 dietary guidelines, in particular reinforcing the importance of eating five fruits and vegetables a day, 
470 consuming adequate protein (0.8g/kg), and limiting SFA and total fat intake. 
471 
472 Physical activity and exercise are clearly important for maintaining and building skeletal muscle at 
473 all ages. So both individual and population approaches for maintaining physical activity are 
474 required (13, 132). Older people should focus on resistance exercise or training, alongside activities 
475 that promote endurance and flexibility, since resistance training promotes rates of protein synthesis 
476 (13, 132). This is particularly important for those with sarcopenic obesity and type 2 diabetes and for 
477 maintaining blood glucose control in diabetes (133). 
478 
479 Clinicians and service providers, such as medical doctors, nurses, and dietitians responsible for 
480 clients in middle and later life need to be particularly aware of the metabolic effects of skeletal 
481 muscle loss with ageing on the metabolism of macronutrients and energy expenditure. In their 
482 practice they should also be aware of these links to the prevention of obesity and their impact on the 
483 onset and treatment of type 2 diabetes. 
484 
485 Given the clear importance of maintaining skeletal muscle mass and quality in regards to the 
486 metabolism and utilisation of macronutrients and overall energy expenditure, as well as links to 
487 obesity and type 2 diabetes, more research is needed on how to preserve healthy skeletal muscle 
488 during ageing. 
489 
490 
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818 
819 Figure legends 
820 
821 Figure 1 
822 Overview of the relationships between age related changes to skeletal muscle macronutrient 
823 metabolism and utilisation, and onset of type 2 diabetes and obesity 
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824 
825 Figure 1 footnote: Circulating glucose arises from metabolism of carbohydrate. 
826 
827 Figure 2 Components of energy expenditure, energy intake and the concept of energy balance in 
828 older adults 
829 
830 Figure 2 footnote: Energy is released from metabolism of the macronutrients protein, carbohydrate 
831 and fat as well as alcohol. Energy expenditure comprises: resting energy expenditure (REE) or basal 
832 metabolic rate (BMR), daily activities and discretionary physical activity (PA) and the thermic 
833 effect of digestion of food. Greater intake of total energy intake than total energy expenditure 
834 results in gain in body weight. 
835 
836 Figure 3 Relationships between age-related changes to morphology and quantity of skeletal muscle, 
837 glucose metabolism, insulin resistance and type 2 diabetes 
838 
839 Figure 3 footnote: The age-related changes in skeletal muscle lead to reduction in glycaemic 
840 control, increased insulin resistance, and onset of type 2 diabetes. That onset of the poor glycaemic 
841 control also accelerates skeletal muscle loss and morphological changes leading to a vicious cycle 
842 of age-related muscle changes in those with type 2 diabetes. 
843 
844 Figure 4 Relationships between age-related changes to morphology and quantity of skeletal muscle 
845 and fatty acid metabolism 
846 
847 Figure 4 footnote: This figure summarises relevance of fatty acids to skeletal muscle changes during 
848 ageing, including increased loss of muscle mass, increased ceramide and fat infiltration, and 
849 reduced ATP production. High total fat intake may cause some skeletal muscle changes directly, but 
850 may also act via inflammatory pathways (also affected by high SFA to PUFA dietary ratios). 
851 Decreased fatty acid utilisation as a result of skeletal muscle changes may feedback so the process 
852 continues. 
853 
854 
855 
856 
857 Table 1. Age-related changes to morphology and quantity of skeletal muscle and interactions 
858 with macronutrient metabolism. 
Fibre Type Ageing Effects Nutrients 
 
 
 
 
 
 
 
859 
Type I (slow) −Oxidative 
> Mitochondria vs Type II 
> Insulin sensitivity vs Type II 
Type II (fast) −Oxidative-Glycolytic (IIa) 
−Glycolytic (IIb) 
↓Number 
↑Proportion 
 
↓Number 
↓Proportion 
Atrophy 
Glucose (↓ with age) 
Fatty acids (↓ with age) 
 
Glucose (↓ with age) 
Fatty acids (↓ with age) 
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